Patents by Inventor Yeong Ho Hong

Yeong Ho Hong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240151361
    Abstract: A hydrogen supply method includes a two-side heat exchange mode in which both introducing a second fluid into a hydrogen storage part after the second fluid exchanges heat with a first fluid in a second heat exchanger in a state in which a compressor is driven to compress the first fluid and introducing the second fluid into the hydrogen storage part after the second fluid is heated or cooled in a thermal device are performed. The method also includes a one-side heat exchange mode in which one of introducing the second fluid into the hydrogen storage part after the second fluid exchanges heat with the first fluid in the second heat exchanger in a state in which the compressor is driven to compress the first fluid and introducing the second fluid into the hydrogen storage part after the second fluid is heated or cooled in the thermal device is performed.
    Type: Application
    Filed: August 30, 2023
    Publication date: May 9, 2024
    Applicants: HYUNDAI MOTOR COMPANY, KIA CORPORATION
    Inventors: Yeon Ho Kim, Hoon Mo Park, Kyung Moon Lee, Dong Hoon Nam, Ji Hye Park, Young Jin Cho, Jea Wan Kim, Byeong Soo Shin, Ji Hoon Lee, Ho Young Jeong, Suk Hoon Hong, Man Hee Park, Yeong Jun Kim, Jae Yeon Kim, Ho Chan An
  • Patent number: 11938236
    Abstract: A dressing is used for curing a wound, and includes a dressing body having a first plane to make contact with a wound of a patient and a second plane opposite to the first surface, a display unit provided on the second plane to display information, and having a flexibility, and a light irradiation device to apply light the wound of the patient. The light irradiation device includes a device board, at least one light emitting diode mounted on the device board, and a water-proof protective film provided on the light emitting diode to protect the light emitting diode.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: March 26, 2024
    Assignee: SEOUL VIOSYS CO., LTD.
    Inventors: Yeong Min Yoon, Hee Ho Bae, A Young Lee, Hyun-Suk Suh, Joon-Pio Hong
  • Patent number: 8691943
    Abstract: NK-2 synthetic peptide derived from cationic core region of porcine NK-lysin has an antimicrobial and antitumor polypeptide that is considered to play a pivotal role in innate defense immunity. To evaluate the antimicrobial properties of synthetic chicken NK-lysin peptides, we investigated cytolytic activity against apicomplexan parasites like Eimeria sporozoites, Neospora tachyzoites and Cryptosporidum sporozoites. The chicken NK-2 (cNK-2) lytic peptide which corresponds to amino acid residues of porcine NK-2 peptide significantly disrupted Eimeria and Cryptosporidum sporozoites and Neospora tachyzoites. In contrast, no bactericidal activity was observed on E. coli BMH71-18. The cNK-2 lytic peptide is novel antimicrobial agent which can be used to intervene and treat economically costly infections in the animal industry.
    Type: Grant
    Filed: March 24, 2011
    Date of Patent: April 8, 2014
    Assignee: The United States of America, as represented by the Secretary of Agriculture
    Inventors: Hyun Soon Lillehoj, Sung Hyen Lee, Yeong ho Hong
  • Publication number: 20120245082
    Abstract: NK-2 synthetic peptide derived from cationic core region of porcine NK-lysin has an antimicrobial and antitumor polypeptide that is considered to play a pivotal role in innate defense immunity. To evaluate the antimicrobial properties of synthetic chicken NK-lysin peptides, we investigated cytolytic activity against apicomplexan parasites like Eimeria sporozoites, Neospora tachyzoites and Cryptosporidum sporozoites. The chicken NK-2 (cNK-2) lytic peptide which corresponds to amino acid residues of porcine NK-2 peptide significantly disrupted Eimeria and Cryptosporidum sporozoites and Neospora tachyzoites. In contrast, no bactericidal activity was observed on E. coli BMH71-18. The cNK-2 lytic peptide is novel antimicrobial agent which can be used to intervene and treat economically costly infections in the animal industry.
    Type: Application
    Filed: March 24, 2011
    Publication date: September 27, 2012
    Inventors: Hyun Soon Lillehoj, Sung Hyen Lee, Yeong ho Hong
  • Patent number: 7754479
    Abstract: The present invention relates to a method for long-term culturing of avian spermatogonial stem cells, which comprises the steps of: (a) preparing an avian testis; (b) isolating a population of testicular cells from said avian testis; and (c) culturing said avian spermatogonial stem cells in said population of testicular cells on a feeder cell layer in a medium containing a cell growth factor, a population of avian spermatogonial stem cells and a method for producing transgenic ayes.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: July 13, 2010
    Assignees: Seoul National University Industry Foundation, Avicore Biotechnology Institute Inc.
    Inventors: Jae Yong Han, Yeong Ho Hong, Jeong Mook Lim, Young Mok Lee, Mak Soon Lee, Jin Gyung Jung
  • Patent number: 7476776
    Abstract: The present invention relates to a method for improving the germline transmission efficiency of avian primordial germ cells (PGCs), and methods for producing avian chimeras and transgenic using it. The present method comprises the steps of (a) isolating primordial germ cells (PGCs) from an avian embryonic gonad; and (b) culturing said PGCs in vitro for at least 5 days. According to the present method, the germline transmission efficiency of PGCs can be dramatically improved in a feasible manner.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: January 13, 2009
    Assignees: Seoul National University Industry Foundation, Avicore Biotechnology Institute Inc., Hanmi Pharm. Co. Ltd.
    Inventors: Jae Yong Han, Tae Sub Park, Yeong Ho Hong, Se Chang Kwon
  • Publication number: 20020138864
    Abstract: The present invention relates to a method for transfection of avian primordial germ cells which comprises a step of electroporating a foreign gene into avian primordial germ cells after addition of dimethylsulfoxide( “DMSO”) to culture medium containing the cells, and a method for production of transgenic Aves by employing the avian primordial germ cells transfected thereby. The DMSO-electroporation method of the invention has various advantages over the conventional transfection methods in light of high transfection efficiency, safety, and simple manipulation. Accordingly, a large number of primordial germ cells transfected with a gene of interest can be efficiently produced by the invention, which, in turn, may increase the rate of transfer of exogenous DNA into recipient embryos.
    Type: Application
    Filed: October 30, 1998
    Publication date: September 26, 2002
    Inventors: JAE YONG HAN, YEONG HO HONG